Search for Clinical Trial Results
Hemoglobinuria, Paroxysmal - 24 Studies Found
Status | Study |
Recruiting |
Study Name: ALXN1210 Versus Eculizumab in Complement Inhibitor Treatment-Naïve Adult Patients With Paroxysmal Nocturnal Hemoglobinuria (PNH) Condition: Paroxysmal Nocturnal Hemoglobinuria (PNH) Date: 2016-10-25 Interventions:
|
Active, not recruiting |
Study Name: A Open-label, Multiple Ascending Dose Study to Evaluate the Efficacy, Safety, Tolerability, Immunogenicity, Pharmacokinetics, and Pharmacodynamics of ALXN1210 Administered Intravenously to Patients With Paroxysmal Nocturnal Hemoglobinuria Condition:
Date: 2015-11-11 Interventions:
|
Active, not recruiting |
Study Name: An Open-Label, Intrapatient, Dose-Escalation Study to Evaluate the Safety, Tolerability, Efficacy, Pharmacokinetics, and Pharmacodynamics of ALXN1210 Administered Intravenously to Patients With Paroxysmal Nocturnal Hemoglobinuria Condition: Paroxysmal Nocturnal Hemoglobinuria (PNH) Date: 2015-11-02 Interventions:
|
Recruiting |
Study Name: Coversin in Paroxysmal Nocturnal Haemoglobinuria (PNH) Condition: Paroxysmal Nocturnal Haemoglobinuria (PNH) Date: 2015-09-10 Interventions: Drug: Coversin Patients enrolled in this protocol will initially be treated with an ablating dose of Cov |